AVNS
insider transactionsAVANOS MEDICAL, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
12.0K sh
Own New
-
Grant·A
Director
$0
12.0K sh
Own New
-
Grant·A
Director
$0
12.0K sh
Own New
-
Grant·A
Director
$0
12.0K sh
Own New
-
Grant·A
Director
$0
12.0K sh
Own New
-
Other·F
SVP, Chief Financial Officer
$104.2K
4.2K sh · $24.64
Own -3%
-
Other·F
SVP, Operations
$105.1K
4.3K sh · $24.64
Own -7%
-
Other·F
David Pacitti KEY
Chief Executive Officer
$307.9K
21.2K sh · $14.53
Own -6%
-
Grant·A
SVP, Operations
$0
37.5K sh
Own +171%
-
Grant·A
SVP, Operations
$0
15.9K sh
Own +36%
-
Grant·A
SVP, Chief Financial Officer
$0
69.6K sh
Own +262%
-
Grant·A
SVP, Chief Financial Officer
$0
29.5K sh
Own +27%
-
Grant·A
David Pacitti KEY
Chief Executive Officer
$0
239.4K sh
Own New
-
Grant·A
David Pacitti KEY
Chief Executive Officer
$0
101.3K sh
Own +42%
-
Grant·A
SVP, Operations
$0
37.8K sh
Own +172%
-
Grant·A
SVP, Operations
$0
15.9K sh
Own +36%
-
Grant·A
David Pacitti KEY
Chief Executive Officer
$0
241.0K sh
Own New
-
Grant·A
David Pacitti KEY
Chief Executive Officer
$0
101.3K sh
Own +42%
-
Grant·A
SVP, Chief Financial Officer
$0
70.1K sh
Own +264%
-
Grant·A
SVP, Chief Financial Officer
$0
29.5K sh
Own +27%
-
Grant·A
Principal Accounting Officer
$0
2.2K sh
Own +19%
-
Grant·A
SVP, Chief Financial Officer
$0
69.6K sh
Own +262%
-
Grant·A
SVP, Chief Financial Officer
$0
29.5K sh
Own +27%
-
Grant·A
David Pacitti KEY
Chief Executive Officer
$0
239.4K sh
Own New
-
Grant·A
David Pacitti KEY
Chief Executive Officer
$0
101.3K sh
Own +42%
-
Grant·A
SVP, Operations
$0
37.5K sh
Own +171%
-
Grant·A
SVP, Operations
$0
15.9K sh
Own +36%
-
Other·F
Principal Accounting Officer
$3.0K
226 sh · $13.29
Own -2%
-
Other·F
SVP, Chief Financial Officer
$14.9K
1.1K sh · $13.29
Own -1%
-
Other·F
Principal Accounting Officer
$2.9K
211 sh · $13.79
Own -2%
-
Other·F
Principal Accounting Officer
$2.0K
144 sh · $13.79
Own -1%
-
Other·F
Principal Accounting Officer
$4.4K
321 sh · $13.79
Own -3%
-
Exercise·M
Principal Accounting Officer
$12.7K
919 sh · $13.79
Own +8%
-
Other·F
SVP, Chief Financial Officer
$28.1K
2.0K sh · $13.79
Own -2%
-
Other·F
SVP, Chief Financial Officer
$14.6K
1.1K sh · $13.79
Own -1%
-
Other·F
SVP, Chief Financial Officer
$32.5K
2.4K sh · $13.79
Own -2%
-
Exercise·M
SVP, Chief Financial Officer
$81.5K
5.9K sh · $13.79
Own +5%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 8, 2026 | BLACKFORD GARY | Grant A | 12.0K | $0 |
| May 8, 2026 | Lisa Egbuonu-Davis | Grant A | 12.0K | $0 |
| May 8, 2026 | Indrani Lall Franchini | Grant A | 12.0K | $0 |
| May 8, 2026 | Patrick J Oleary | Grant A | 12.0K | $0 |
| May 8, 2026 | Julie Ann Shimer | Grant A | 12.0K | $0 |
| Apr 22, 2026 | Scott Michael Galovan KEY | Other F | 4.2K | $104.2K |
| Apr 22, 2026 | Sigfrido Delgado | Other F | 4.3K | $105.1K |
| Apr 14, 2026 | David Pacitti KEY | Other F | 21.2K | $307.9K |
| Mar 13, 2026 | Sigfrido Delgado | Grant A | 37.5K | $0 |
| Mar 13, 2026 | Sigfrido Delgado | Grant A | 15.9K | $0 |
| Mar 13, 2026 | Scott Michael Galovan KEY | Grant A | 69.6K | $0 |
| Mar 13, 2026 | Scott Michael Galovan KEY | Grant A | 29.5K | $0 |
| Mar 13, 2026 | David Pacitti KEY | Grant A | 239.4K | $0 |
| Mar 13, 2026 | David Pacitti KEY | Grant A | 101.3K | $0 |
| Mar 13, 2026 | Sigfrido Delgado | Grant A | 37.8K | $0 |
| Mar 13, 2026 | Sigfrido Delgado | Grant A | 15.9K | $0 |
| Mar 13, 2026 | David Pacitti KEY | Grant A | 241.0K | $0 |
| Mar 13, 2026 | David Pacitti KEY | Grant A | 101.3K | $0 |
| Mar 13, 2026 | Scott Michael Galovan KEY | Grant A | 70.1K | $0 |
| Mar 13, 2026 | Scott Michael Galovan KEY | Grant A | 29.5K | $0 |
| Mar 13, 2026 | John Joseph Hurley | Grant A | 2.2K | $0 |
| Mar 13, 2026 | Scott Michael Galovan KEY | Grant A | 69.6K | $0 |
| Mar 13, 2026 | Scott Michael Galovan KEY | Grant A | 29.5K | $0 |
| Mar 13, 2026 | David Pacitti KEY | Grant A | 239.4K | $0 |
| Mar 13, 2026 | David Pacitti KEY | Grant A | 101.3K | $0 |
| Mar 13, 2026 | Sigfrido Delgado | Grant A | 37.5K | $0 |
| Mar 13, 2026 | Sigfrido Delgado | Grant A | 15.9K | $0 |
| Mar 9, 2026 | John Joseph Hurley | Other F | 226 | $3.0K |
| Mar 9, 2026 | Scott Michael Galovan KEY | Other F | 1.1K | $14.9K |
| Mar 6, 2026 | John Joseph Hurley | Other F | 211 | $2.9K |
| Mar 6, 2026 | John Joseph Hurley | Other F | 144 | $2.0K |
| Mar 6, 2026 | John Joseph Hurley | Other F | 321 | $4.4K |
| Mar 6, 2026 | John Joseph Hurley | Exercise M | 919 | $12.7K |
| Mar 6, 2026 | Scott Michael Galovan KEY | Other F | 2.0K | $28.1K |
| Mar 6, 2026 | Scott Michael Galovan KEY | Other F | 1.1K | $14.6K |
| Mar 6, 2026 | Scott Michael Galovan KEY | Other F | 2.4K | $32.5K |
| Mar 6, 2026 | Scott Michael Galovan KEY | Exercise M | 5.9K | $81.5K |
About AVNS insider trading
This page tracks insider transactions for AVANOS MEDICAL, INC. (AVNS) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.